 |
| On the 11th, foreign immigrants from Incheon International Airport Terminal 1 are entering the arrival hall. 2021.1.11/News1 © News1 Reporter Seongcheol Lee |
The quarantine authorities said, “Recently, the challenge of the novel coronavirus infection (Corona 19) is increasing. The emergence of mutations is the key,” he said, and in the worst case, there may be problems with the effectiveness of treatments and vaccines.
Accordingly, it is planned to conduct a cell-level experiment to see if the antibody therapy, which is currently undergoing clinical trials in Korea, is effective against mutant viruses of the UK and South Africa. The policy is to derive results before the Lunar New Year holidays.
On the 23rd, Kwon Jun-wook, head of the second division of the Central Defense Response Headquarters, said at a regular briefing on Corona 19, “The National Institute of Disease Control and Prevention has secured mutants in the UK and South Africa on the 21st and plans to evaluate the efficacy of antibody treatments at the cell line level,” he said. .
Deputy General Manager Kwon said, “There are announcements that the spread speed as well as the severity will increase as various mutations are discovered one after another in various parts of the world.”
According to the announcement of the British government, a major variation in the UK is confirmed every two weeks. Infectious power is higher than 30-70%, and fatality rate over 60 years old is 30% higher.
Accordingly, the plan is to evaluate the efficacy of antibody treatments being developed in Korea.
Celltrion’s Corona 19 antibody treatment,’Rekirona’, is currently being reviewed by the Ministry of Food and Drug Safety, and is scheduled to undergo phase 3 clinical trials according to the final approval review results.
“Therapies and vaccines are also facing challenges. In the worst case, we cannot rule out the possibility of problems with the effects.” I will give it to you.”
Meanwhile, one researcher-led clinical trial was approved for Celltrion’s antibody treatment. Since researcher-led clinical trials are not sponsor-led clinical trials, independent research is possible on new efficacy, effects, usage and dosage of the drug.
According to the quarantine authorities, on the 13th, the Incheon Medical Center was approved for clinical trials by researchers on 20 mild and moderate corona19 patients.